Here is what Tony said clearly in the last conf call
"...member. In closing, I want to make or review a couple of the upcoming milestones. We expect to complete enrollment in our Phase 3 PRO 140 combination trial by the end of June. Clearly, there will be an additional week of data compilation and as more data becomes available to us, we will be reporting it through press releases."
I asked the question on the PR content language as they did not give the viral load reduction after 1 week as before and promised.
When co changed the direction that promised before - well I need to be skeptical.
Thanks Salt. I'm assuming the data is definitely still blinded since the 34th patient was likely enrolled this week.
Clarifying question: the PR seems positive with all facts, why did you mention you would have a hard time staying in without tony at this point? Is there something worrying you in this Pr that I don't see?
News 
Market Data 
Discover 
AI
